These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 11602410

  • 1. Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.
    Lauria F, Lenoci M, Annino L, Raspadori D, Marotta G, Bocchia M, Forconi F, Gentili S, La Manda M, Marconcini S, Tozzi M, Baldini L, Zinzani PL, Foà R.
    Haematologica; 2001 Oct; 86(10):1046-50. PubMed ID: 11602410
    [Abstract] [Full Text] [Related]

  • 2. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D.
    Srp Arh Celok Lek; 2000 Oct; 128(7-8):262-70. PubMed ID: 11089434
    [Abstract] [Full Text] [Related]

  • 3. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
    Gellrich S, Muche JM, Wilks A, Jasch KC, Voit C, Fischer T, Audring H, Sterry W.
    Br J Dermatol; 2005 Jul; 153(1):167-73. PubMed ID: 16029344
    [Abstract] [Full Text] [Related]

  • 4. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

  • 5. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
    Lauria F, Bocchia M, Marotta G, Raspadori D, Zinzani PL, Rondelli D.
    Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
    [Abstract] [Full Text] [Related]

  • 6. Rituximab as treatment for minimal residual disease in hairy cell leukaemia.
    Cervetti G, Galimberti S, Andreazzoli F, Fazzi R, Cecconi N, Caracciolo F, Petrini M.
    Eur J Haematol; 2004 Dec; 73(6):412-7. PubMed ID: 15522063
    [Abstract] [Full Text] [Related]

  • 7. B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
    Zaja F, Vianelli N, Sperotto A, De Vita S, Iacona I, Zaccaria A, Masolini P, Tomadini V, Tani M, Molinari AL, Baccarani M, Fanin R.
    Haematologica; 2003 May; 88(5):538-46. PubMed ID: 12745273
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma.
    Tobinai K, Ogura M, Kobayashi Y, Uchida T, Watanabe T, Oyama T, Maruyama D, Suzuki T, Mori M, Kasai M, Cronier D, Wooldridge JE, Koshiji M.
    Cancer Sci; 2011 Feb; 102(2):432-8. PubMed ID: 21205069
    [Abstract] [Full Text] [Related]

  • 11. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P, Caulet-Maugendre S, Foussard C, Salles G, Moreau A, Rossi JF, Patey M, Rousselet MC, Bene MC, Damotte D, Cornillet Lefebvre P, Martin A, Costes V, GOELAMS group.
    Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
    [Abstract] [Full Text] [Related]

  • 12. [Complete remission after Rituximab treatment in refractory hairy cell leukemia].
    Petruskevicius I, Bukh A, Mertz H, Johnsen HE.
    Ugeskr Laeger; 2008 Jun 23; 170(26-32):2350. PubMed ID: 18570771
    [Abstract] [Full Text] [Related]

  • 13. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia.
    Treon SP, Agus TB, Link B, Rodrigues G, Molina A, Lacy MQ, Fisher DC, Emmanouilides C, Richards AI, Clark B, Lucas MS, Schlossman R, Schenkein D, Lin B, Kimby E, Anderson KC, Byrd JC.
    J Immunother; 2001 Jun 23; 24(3):272-9. PubMed ID: 11394506
    [Abstract] [Full Text] [Related]

  • 14. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G, Schirmer M, Hilbe W, Fend F, Geisen F, Knoblechner A, Petzer A, Thaler J.
    Blood Cells Mol Dis; 1995 Jun 23; 21(2):142-51. PubMed ID: 8846043
    [Abstract] [Full Text] [Related]

  • 15. [Hairy cell leukemia successfully treated with deoxycoformycin].
    Matsuda A, Jinnai I, Mizuno H, Sakata T, Kusumoto S, Kayano H, Takeuchi H, Bessho M, Saito M, Katayama I.
    Rinsho Ketsueki; 1992 Nov 23; 33(11):1685-90. PubMed ID: 1469784
    [Abstract] [Full Text] [Related]

  • 16. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.
    Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard JP, Amadori S, Bussel JB.
    Br J Haematol; 2004 Apr 23; 125(2):232-9. PubMed ID: 15059147
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
    Treon SP, Shima Y, Preffer FI, Doss DS, Ellman L, Schlossman RL, Grossbard ML, Belch AR, Pilarski LM, Anderson KC.
    Semin Oncol; 1999 Oct 23; 26(5 Suppl 14):97-106. PubMed ID: 10561024
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Al-Ali HK, Wittekind C, Niederwieser D.
    Dtsch Med Wochenschr; 2007 Aug 23; 132(33):1688-91. PubMed ID: 17713864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.